Jump Financial, LLC Akebia Therapeutics, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.27 - $2.24 $53,238 - $93,900	41,920 New	41,920 $76,000
Q4 2021 Feb 10, 2022	SELL	$2.26 - $3.34 $344,197 - $508,682	-152,300 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $189,652 - $313,127	-80,703 Reduced 34.64%	152,300 $439,000
Q2 2021 Aug 13, 2021	BUY	$2.83 - $4.2 $280,455 - $416,224	99,101 Added 74.01%	233,003 $883,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.06 $63,308 - $109,705	-21,681 Reduced 13.94%	133,902 $453,000
Q4 2020 Feb 12, 2021	SELL	$2.22 - $3.78 $99,715 - $169,786	-44,917 Reduced 22.4%	155,583 $435,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $479,195 - $2.62 Million	200,500 New	200,500 $503,000

127

56.5M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $386M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.